You have Guest access.
Log In
Godefridus J. Peters
i-xiii
Front matter
1-28
Nucleoside Transport Into Cells Role of Nucleoside Transporters SLC28 and SLC29 in Cancer Chemotherapy
29-52
The Role of Deoxycytidine Kinase in DNA Synthesis and Nucleoside Analog Activation
53-79
Deoxynucleoside Kinases and Their Potential Role in Deoxynucleoside Cytotoxicity
81-108
Nucleotidases and Nucleoside Analog Cytotoxicity
109-117
Pumping Out Drugs The Potential Impact of ABC Transporters on Resistance to Base, Nucleoside, and Nucleotide Analogs*
119-152
Cytosine Arabinoside Metabolism, Mechanisms of Resistance, and Clinical Pharmacology
153-171
Clofarabine Mechanisms of Action, Pharmacology, and Clinical Investigations
173-198
L-Nucleosides as Chemotherapeutic Agents
199-214
Troxacitabine (Troxatyl ™) A Deoxycytidine Nucleoside Analog With Potent Antitumor Activity
215-224
9-β-D-Arabinofuranosylguanine
225-251
Gemcitabine Mechanism of Action and Resistance
253-288
Clinical Activity of Gemcitabine as a Single Agent and in Combination
289-329
Nucleoside Radiosensitizers
331-352
NONMEM Population Models of Cytosine Arabinoside and Fludarabine Phosphate in Pediatric Patients With Leukemia
353-401
ThecycloSal-Nucleotide Delivery System Development of Chemical Trojan Horses as Antiviral Agents
403-439
Purine and Pyrimidine-Based Analogs and Suicide Gene Therapy
441-462
3′-Deoxy-3′-Fluorothymidine as a Tracer of Proliferation in Positron Emission Tomography
463-476
Back matter
This page requires script.
Frequently asked questions General info on journals and books Send us your feedback Impressum Contact us
© Springer, Part of Springer Science+Business Media Privacy, Disclaimer, Terms & Conditions, and Copyright Info